Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): A SEER-Medicare analysis. This is an ASCO ...
MANASSAS, Va., Jan. 5, 2026 /PRNewswire/ -- PureHealth Research announces their collection of supplements for nervous system support, designed for biohackers, executives, and wellness optimizers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback